The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol
<p>Abstract</p> <p>Background</p> <p>There is no recommendation to screen ferritin level in blood donors, even though several studies have noted the high prevalence of iron deficiency after blood donation, particularly among menstruating females. Furthermore, some clini...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-01-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/10/1/4 |
| _version_ | 1811260047807741952 |
|---|---|
| author | Tissot Jean-Daniel Bize Raphael Vaucher Paul Cornuz Jacques Waldvogel Sophie Pedrazzini Baptiste Pecoud Alain Favrat Bernard |
| author_facet | Tissot Jean-Daniel Bize Raphael Vaucher Paul Cornuz Jacques Waldvogel Sophie Pedrazzini Baptiste Pecoud Alain Favrat Bernard |
| author_sort | Tissot Jean-Daniel |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>There is no recommendation to screen ferritin level in blood donors, even though several studies have noted the high prevalence of iron deficiency after blood donation, particularly among menstruating females. Furthermore, some clinical trials have shown that non-anaemic women with unexplained fatigue may benefit from iron supplementation. Our objective is to determine the clinical effect of iron supplementation on fatigue in female blood donors without anaemia, but with a mean serum ferritin ≤ 30 ng/ml.</p> <p>Methods/Design</p> <p>In a double blind randomised controlled trial, we will measure blood count and ferritin level of women under age 50 yr, who donate blood to the University Hospital of Lausanne Blood Transfusion Department, at the time of the donation and after 1 week. One hundred and forty donors with a ferritin level ≤ 30 ng/ml and haemoglobin level ≥ 120 g/l (non-anaemic) a week after the donation will be included in the study and randomised. A one-month course of oral ferrous sulphate (80 mg/day of elemental iron) will be introduced vs. placebo. Self-reported fatigue will be measured using a visual analogue scale. Secondary outcomes are: score of fatigue (Fatigue Severity Scale), maximal aerobic power (Chester Step Test), quality of life (SF-12), and mood disorders (Prime-MD). Haemoglobin and ferritin concentration will be monitored before and after the intervention.</p> <p>Discussion</p> <p>Iron deficiency is a potential problem for all blood donors, especially menstruating women. To our knowledge, no other intervention study has yet evaluated the impact of iron supplementation on subjective symptoms after a blood donation.</p> <p>Trial registration</p> <p>NCT00689793</p> |
| first_indexed | 2024-04-12T18:40:40Z |
| format | Article |
| id | doaj.art-801c3da1e2ad41399c9911442815f163 |
| institution | Directory Open Access Journal |
| issn | 1745-6215 |
| language | English |
| last_indexed | 2024-04-12T18:40:40Z |
| publishDate | 2009-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj.art-801c3da1e2ad41399c9911442815f1632022-12-22T03:20:47ZengBMCTrials1745-62152009-01-01101410.1186/1745-6215-10-4The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocolTissot Jean-DanielBize RaphaelVaucher PaulCornuz JacquesWaldvogel SophiePedrazzini BaptistePecoud AlainFavrat Bernard<p>Abstract</p> <p>Background</p> <p>There is no recommendation to screen ferritin level in blood donors, even though several studies have noted the high prevalence of iron deficiency after blood donation, particularly among menstruating females. Furthermore, some clinical trials have shown that non-anaemic women with unexplained fatigue may benefit from iron supplementation. Our objective is to determine the clinical effect of iron supplementation on fatigue in female blood donors without anaemia, but with a mean serum ferritin ≤ 30 ng/ml.</p> <p>Methods/Design</p> <p>In a double blind randomised controlled trial, we will measure blood count and ferritin level of women under age 50 yr, who donate blood to the University Hospital of Lausanne Blood Transfusion Department, at the time of the donation and after 1 week. One hundred and forty donors with a ferritin level ≤ 30 ng/ml and haemoglobin level ≥ 120 g/l (non-anaemic) a week after the donation will be included in the study and randomised. A one-month course of oral ferrous sulphate (80 mg/day of elemental iron) will be introduced vs. placebo. Self-reported fatigue will be measured using a visual analogue scale. Secondary outcomes are: score of fatigue (Fatigue Severity Scale), maximal aerobic power (Chester Step Test), quality of life (SF-12), and mood disorders (Prime-MD). Haemoglobin and ferritin concentration will be monitored before and after the intervention.</p> <p>Discussion</p> <p>Iron deficiency is a potential problem for all blood donors, especially menstruating women. To our knowledge, no other intervention study has yet evaluated the impact of iron supplementation on subjective symptoms after a blood donation.</p> <p>Trial registration</p> <p>NCT00689793</p>http://www.trialsjournal.com/content/10/1/4 |
| spellingShingle | Tissot Jean-Daniel Bize Raphael Vaucher Paul Cornuz Jacques Waldvogel Sophie Pedrazzini Baptiste Pecoud Alain Favrat Bernard The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol Trials |
| title | The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol |
| title_full | The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol |
| title_fullStr | The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol |
| title_full_unstemmed | The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol |
| title_short | The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol |
| title_sort | impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia rationale and design of a randomised controlled trial a study protocol |
| url | http://www.trialsjournal.com/content/10/1/4 |
| work_keys_str_mv | AT tissotjeandaniel theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT bizeraphael theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT vaucherpaul theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT cornuzjacques theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT waldvogelsophie theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT pedrazzinibaptiste theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT pecoudalain theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT favratbernard theimpactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT tissotjeandaniel impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT bizeraphael impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT vaucherpaul impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT cornuzjacques impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT waldvogelsophie impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT pedrazzinibaptiste impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT pecoudalain impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol AT favratbernard impactofironsupplementationefficiencyinfemaleblooddonorswithadecreasedferritinlevelandnoanaemiarationaleanddesignofarandomisedcontrolledtrialastudyprotocol |